Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
441
-
Total 13F shares, excl. options
-
58.4M
-
Shares change
-
+978K
-
Total reported value, excl. options
-
$7.22B
-
Value change
-
+$74.5M
-
Put/Call ratio
-
8.64
-
Number of buys
-
198
-
Number of sells
-
-241
-
Price
-
$124.38
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2025
524 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2025.
REPLIGEN CORP - COMMON STOCK (RGEN) has 441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.4M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (6.6M shares), BlackRock, Inc. (6.08M shares), VANGUARD GROUP INC (5.08M shares), Point72 Asset Management, L.P. (1.91M shares), STATE STREET CORP (1.62M shares), FMR LLC (1.61M shares), Champlain Investment Partners, LLC (1.4M shares), Invesco Ltd. (1.38M shares), Bank of New York Mellon Corp (1.32M shares), and SANDS CAPITAL MANAGEMENT, LLC (1.25M shares).
This table shows the top 441 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.